Heart Failure: Finerenone Study

We are testing the medication finerenone for patients with heart failure who cannot tolerate standard treatments. The study aims to see if it is safe and effective for these individuals.

>2 years ≤5 visits Confirmation phase (III)Cost Reimbursement Partially Remote Investigational Medicines OralCardiologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Finerenone

Finerenone is a substance that helps protect the kidneys and heart in adults with chronic kidney disease related to type 2 diabetes.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Bay 94-8862

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Internacionalni medicinski centar PRIORA

Department of Internal Medicine and Cardiology

Čepin, Croatia

Specijalna Bolnica Za Medicinsku Rehabilitaciju Krapinske Toplice

Cardiac rehabilitation department

Krapina, Croatia

Klinicki Bolnicki Centar Osijek

Department of Heart and Vascular Diseases

Osijek, Croatia

Sponsor: Colorado Prevention Center

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.